Home   Search   Browse   Statistics   User guide   FAQs   Post question   Download   Process data  
Search results for the GEO ID: GSE7538
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM182629
GPL570
CD34AML_PTL_6 h_patient_1 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with PTL CD34+ AML Patient 1 Treatment with PTL 6 h CD34+ AML Patient 1 Treatment with PTL 6 h
GSM182630
GPL570
CD34AML_UT_6 h_patient_1 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with UT CD34+ AML Patient 1 Treatment with UT 6 h CD34+ AML Patient 1 Treatment with UT 6 h
GSM182631
GPL570
CD34AML_PTL_6 h_patient_10 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with PTL CD34+ AML Patient 10 Treatment with PTL 6 h CD34+ AML Patient 10 Treatment with PTL 6 h
GSM182632
GPL570
CD34AML_UT_6 h_patient_10 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with UT CD34+ AML Patient 10 Treatment with UT 6 h CD34+ AML Patient 10 Treatment with UT 6 h
GSM182633
GPL570
CD34AML_PTL_6 h_patient_11 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with PTL CD34+ AML Patient 11 Treatment with PTL 6 h CD34+ AML Patient 11 Treatment with PTL 6 h
GSM182634
GPL570
CD34AML_UT_6 h_patient_11 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with UT CD34+ AML Patient 11 Treatment with UT 6 h CD34+ AML Patient 11 Treatment with UT 6 h
GSM182635
GPL570
CD34AML_PTL_6 h_patient_12 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with PTL CD34+ AML Patient 12 Treatment with PTL 6 h CD34+ AML Patient 12 Treatment with PTL 6 h
GSM182636
GPL570
CD34AML_UT_6 h_patient_12 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with UT CD34+ AML Patient 12 Treatment with UT 6 h CD34+ AML Patient 12 Treatment with UT 6 h
GSM182637
GPL570
CD34AML_PTL_6 h_patient_13 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with PTL CD34+ AML Patient 13 Treatment with PTL 6 h CD34+ AML Patient 13 Treatment with PTL 6 h
GSM182638
GPL570
CD34AML_UT_6 h_patient_13 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with UT CD34+ AML Patient 13 Treatment with UT 6 h CD34+ AML Patient 13 Treatment with UT 6 h
GSM182639
GPL570
CD34AML_PTL_6 h_patient_2 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with PTL CD34+ AML Patient 2 Treatment with PTL 6 h CD34+ AML Patient 2 Treatment with PTL 6 h
GSM182640
GPL570
CD34AML_UT_6 h_patient_2 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with UT CD34+ AML Patient 2 Treatment with UT 6 h CD34+ AML Patient 2 Treatment with UT 6 h
GSM182641
GPL570
CD34AML_PTL_6 h_patient_3 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with PTL CD34+ AML Patient 3 Treatment with PTL 6 h CD34+ AML Patient 3 Treatment with PTL 6 h
GSM182642
GPL570
CD34AML_UT_6 h_patient_3 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with UT CD34+ AML Patient 3 Treatment with UT 6 h CD34+ AML Patient 3 Treatment with UT 6 h
GSM182643
GPL570
CD34AML_PTL_6 h_patient_4 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with PTL CD34+ AML Patient 4 Treatment with PTL 6 h CD34+ AML Patient 4 Treatment with PTL 6 h
GSM182644
GPL570
CD34AML_UT_6 h_patient_4 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with UT CD34+ AML Patient 4 Treatment with UT 6 h CD34+ AML Patient 4 Treatment with UT 6 h
GSM182645
GPL570
CD34AML_PTL_6 h_patient_5 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with PTL CD34+ AML Patient 5 Treatment with PTL 6 h CD34+ AML Patient 5 Treatment with PTL 6 h
GSM182646
GPL570
CD34AML_UT_6 h_patient_5 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with UT CD34+ AML Patient 5 Treatment with UT 6 h CD34+ AML Patient 5 Treatment with UT 6 h
GSM182647
GPL570
CD34AML_PTL_6 h_patient_6 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with PTL CD34+ AML Patient 6 Treatment with PTL 6 h CD34+ AML Patient 6 Treatment with PTL 6 h
GSM182648
GPL570
CD34AML_UT_6 h_patient_6 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with UT CD34+ AML Patient 6 Treatment with UT 6 h CD34+ AML Patient 6 Treatment with UT 6 h
GSM182649
GPL570
CD34AML_PTL_6 h_patient_7 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with PTL CD34+ AML Patient 7 Treatment with PTL 6 h CD34+ AML Patient 7 Treatment with PTL 6 h
GSM182650
GPL570
CD34AML_UT_6 h_patient_7 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with UT CD34+ AML Patient 7 Treatment with UT 6 h CD34+ AML Patient 7 Treatment with UT 6 h
GSM182651
GPL570
CD34AML_PTL_6 h_patient_8 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with PTL CD34+ AML Patient 8 Treatment with PTL 6 h CD34+ AML Patient 8 Treatment with PTL 6 h
GSM182652
GPL570
CD34AML_UT_6 h_patient_8 CD34+ Primary Acute Myelogenous Leukemia, 6 h post-treatment with UT CD34+ AML Patient 8 Treatment with UT 6 h CD34+ AML Patient 8 Treatment with UT 6 h
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes